IL6 and COVID-19: Clinical trials and reports had shown that IL-6 played an important role in the pathogenesis and severity of COVID-19 (Pelaia et al., 2021), inhibiting the IL6 receptor could effectively reduce mortality or the side effects of COVID-19 (Gupta et al., 2021).